Item type:Thesis, Open Access

Regulation von Osteoprotegerin (OPG) und Receptor activator of nuclear factor-κB ligand (RANKL) in humanen Schilddrüsenkarzinomzellen

Thumbnail Image

Files

dnb.pdf (2.22 MB)

Date

2006-10-05

relationships.isAuthorOf

Publisher

Philipps-Universität Marburg
DOI

item.page.supervisor-of-thesis

Abstract

The dissertation is concerned with the evidence and regulation of OPG (Osteoprotegerin) and RANKL (Receptor activator of nuclear factor ĸB ligand) in human thyroid cancer cells. The cells used were SW579 (anaplastic), HTC+ and XTC (both follicular). These were stimulated with steroid hormones, drugs and Il-1β and examined by Northern blot and ELISA.

Review

Metadata

Contributors
Supervisor:
Dates
Created: 2006Issued: 2006-10-05Updated: 2011-08-10
DOI
https://doi.org/10.17192/z2006.0692
Faculty
Medizin
Publisher
Philipps-Universität Marburg
Language
ger
Data types
DoctoralThesis
Keywords
OPGThyroid cancerThyroidRANKL
DFG-subjects
SchilddrüseSchilddrüsenkarzinomOPGRANKL
DDC-Numbers
610
License
https://rightsstatements.org/vocab/InC-NC/1.0/
URI
https://open.uni-marburg.de/handle/10.17192/z2006.0692
show more
Brulez, Nele (13214445X): Regulation von Osteoprotegerin (OPG) und Receptor activator of nuclear factor-κB ligand (RANKL) in humanen Schilddrüsenkarzinomzellen. : Philipps-Universität Marburg 2006-10-05. DOI: https://doi.org/10.17192/z2006.0692.

License

item.page.license.under-copyright
This item has been published with the following license: In Copyright